David Sherris
Fondateur chez Paloma Pharmaceuticals, Inc.
Provenance du réseau au premier degré de David Sherris
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
RestorGenex Corp.
 RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL.
19
| Extinct | Pharmaceuticals: Major | 19 |
Paloma Pharmaceuticals, Inc.
 Paloma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Paloma Pharmaceuticals, Inc. manufactures pharmaceutical drugs and related products. The firm’s product Cialis which develops drugs for cancer, ocular diseases, arthritis, fibrotic diseases, antiviral, skin diseases and erectile dysfunction. The company is headquartered in Jamaica Plain, MA.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à David Sherris via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| CELGENE | Biotechnology | Founder Chief Executive Officer | |
| Rochester Christian University | College/University | Graduate Degree | |
| 3I GROUP PLC | Investment Managers | Private Equity Investor | |
| ANI PHARMACEUTICALS, INC. | Biotechnology | President Director of Finance/CFO | |
Diffusion Pharmaceuticals LLC
 Diffusion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals LLC develops and manufactures pharmaceutical products. The firm develops trans sodium crocetinate for use in cancers types in which tumor hypoxia (oxygen deprivation) is known to diminish the effectiveness of current treatments. The company was founded by Matthew W. Hantzmon, John L. Gainer, and David G. Kalergis in February 2001 and is headquartered in Charlottesville, VA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Founder Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| GREENWOOD HALL, INC. | Miscellaneous Commercial Services | Director/Board Member Chief Operating Officer | |
| CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Director/Board Member Founder | |
MDRejuvena, Inc.
 MDRejuvena, Inc. Pharmaceuticals: MajorHealth Technology MDRejuvena, Inc. manufactures skin care products. It specializes in providing products that rejuvenate, enhance and maintain skin health for the patients of physicians and skincare professionals worldwide. The company was founded by David F. Hale in 2013 and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director/Board Member | |
| University of Virginia | College/University | General Counsel Corporate Officer/Principal Graduate Degree Corporate Officer/Principal | |
Oak Investment Partners
 Oak Investment Partners Investment ManagersFinance Oak Investment Partners (Oak Investment Partners) is a venture capital firm founded in 1978 by Ed F Glassmeyer and Stewart H Greenfield. The firm is headquartered in Wilton, Connecticut. | Investment Managers | Corporate Officer/Principal | |
Virginia National Bank (Charlottesville)
 Virginia National Bank (Charlottesville) Major BanksFinance Virginia National Bank provides banking and financial services. The firm operates through two segments: The Commercial Bank and VNB Trust. The Commercial Bank segment involves making loans and generating deposits from individuals and businesses. The VNB Trust segment offers services, which include investment management, trust account administration and estate planning. It offers personal banking, business banking and treasury management services. The company was founded on July 29, 1998 and is headquartered in Charlottesville, VA. | Major Banks | Chief Executive Officer Director/Board Member | |
Gynex Pharmaceuticals, Inc.
 Gynex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Gynex Pharmaceuticals, Inc. is a pharmaceutical concern. The company is based in Vernon Hills, IL. Gynex Pharmaceuticals was acquired by Savient Pharmaceuticals, Inc. on August 09, 1993 for $47.87 million. | Pharmaceuticals: Major | Chief Executive Officer Comptroller/Controller/Auditor | |
| Brooklyn College | College/University | Undergraduate Degree Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Undergraduate Degree | |
| Yale University | College/University | Graduate Degree Undergraduate Degree | |
| New York University | College/University | Masters Business Admin Masters Business Admin | |
| West Virginia University | College/University | Undergraduate Degree Doctorate Degree | |
The Paramount Theater /WA/
 The Paramount Theater /WA/ Movies/EntertainmentConsumer Services The Paramount Theater offers architectural majesty and viewed countless films. The company was founded on march 1, 1928 and is headquartered in Seattle, WA. | Movies/Entertainment | Director/Board Member | |
Society of Kauffman Fellows
 Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Xbio Systems, Inc.
 Xbio Systems, Inc. Information Technology ServicesTechnology Services Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle. | Information Technology Services | Director/Board Member | |
| CONTRAFECT CORPORATION | Biotechnology | Director/Board Member Chairman | |
| SPENDSMART NETWORKS, INC. | Advertising/Marketing Services | Chief Executive Officer Director/Board Member President | |
Nixon & Vanderhye P.C.
 Nixon & Vanderhye P.C. Miscellaneous Commercial ServicesCommercial Services Nixon & Vanderhye P.C. engages in the provision of legal services. It offers patent prosecution and litigation, trademarks, post grant proceedings, internet protocol due diligence, and transactional practice, licensing, and copyrights services. The firm serves the biotechnology and life sciences, chemical and pharmaceutical, electronics, computer technology, communications and software, and the mechanical arts industries. The company was founded in 1985 and is headquartered in Arlington, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| INSPIREMD, INC. | Medical Specialties | Director/Board Member Chairman | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chairman | |
WaveGuide Corp.
 WaveGuide Corp. Medical SpecialtiesHealth Technology Waveguide Corp. operates as an analytical instrument company. The firm develops medical and industrial diagnostic devices with core expertise in three domains: custom ASICs; embedded systems & algorithms; and customized, functionalized magnetic nanoparticles. It focuses on developing its portable micro-nuclear magnetic resonance (µNMR) platform technology. The company was founded by Marcus Semones in 2015 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Chief Executive Officer | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member President | |
| ADHERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Biotechnology | Founder Director/Board Member | |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020. | Medical/Nursing Services | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
BlinkTBI, Inc.
 BlinkTBI, Inc. Data Processing ServicesTechnology Services Blinktbi, Inc. engages in the development of a eye test technology that provides objective data about neurological function to support medical personnel. The company was is headquartered in Charleston, SC. | Data Processing Services | Director/Board Member | |
| VYNE THERAPEUTICS INC. | Director/Board Member | ||
Zerigo Health, Inc.
 Zerigo Health, Inc. Medical SpecialtiesHealth Technology Zerigo Health, Inc. develops handheld ultra violet device. It offers therapy to psoriasis, eczema, and vitiligo patients. The company was founded by Martyn Gross and Remo Qajar in 2014 and is headquartered in San Diego, CA. | Medical Specialties | Chief Executive Officer | |
Expedition Trust Co.
 Expedition Trust Co. Investment Banks/BrokersFinance Expedition Trust Co. provides client-first service which is independent, efficient, and transparent. It offers open architecture asset management, trusteeships, custodian, and executor services. The firm’s situs trust includes directed trusts, dynasty trusts, asset protection trusts, captive insurance trusts, and the full panoply of tax and flexibility. The company was founded by Eugene V. Fife and Donald A. King, Jr. and is headquartered in Charlottesville, VA. | Investment Banks/Brokers | Chairman |
Statistiques
Internationale
| Etats-Unis | 40 |
| Australie | 4 |
| Royaume-Uni | 2 |
| France | 2 |
| Israël | 2 |
Sectorielle
| Health Technology | 24 |
| Consumer Services | 10 |
| Finance | 5 |
| Commercial Services | 5 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 139 |
| Corporate Officer/Principal | 56 |
| Independent Dir/Board Member | 41 |
| Chairman | 35 |
| Chief Executive Officer | 27 |
Relations les plus connectées
| Insiders | |
|---|---|
| Isaac Blech | 32 |
| Sol Barer | 32 |
| Mark T. Giles | 29 |
| Rex Bright | 24 |
| Jerold Howard Rubinstein | 18 |
| Nelson K. Stacks | 17 |
| Alan Levin | 17 |
| Philip Donenberg | 15 |
| Sukumar Nagendran | 15 |
| Stephen Simes | 14 |
| Daniel L. Menichella | 13 |
| Yael Schwartz | 11 |
| John F. Moynahan | 10 |
| Robert W. Adams | 10 |
| Timothy Boris | 9 |
- Bourse
- Insiders
- David Sherris
- Connexions Sociétés
